Can live-attenuated SARS-CoV-2 vaccine contribute to stopping the pandemic?

Tang, Patrick Chun Hean; Ng, Wern Hann; King, Nicholas J C; Mahalingam, Suresh

Tang, Patrick Chun Hean; Ng, Wern Hann; King, Nicholas J C; Mahalingam, Suresh.

Tang PCH; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
Ng WH; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
King NJC; Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Queensland, Australia.
Mahalingam S; The Discipline of Pathology and Bosch Institute, School of Medical Sciences, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia.

PLoS Pathog ; 18(9): e1010821, 2022 09.

Article in English | MEDLINE | ID: covidwho-2039446

Subject(s)

COVID-19; Viral Vaccines; COVID-19/prevention & control; COVID-19 Vaccines; Humans; Pandemics/prevention & control; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Viral Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: PLoS Pathog Year: 2022 Document Type: Article Affiliation country: Journal.ppat.1010821

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google